Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection.

Moriarty LF, Omer SB.

Hum Vaccin Immunother. 2014;10(9):2721-8. doi: 10.4161/hv.29669. Review.

2.

Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Chaussee MS, Sandbulte HR, Schuneman MJ, Depaula FP, Addengast LA, Schlenker EH, Huber VC.

Vaccine. 2011 May 12;29(21):3773-81. doi: 10.1016/j.vaccine.2011.03.031. Epub 2011 Apr 8.

3.

Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.

He XS, Holmes TH, Sasaki S, Jaimes MC, Kemble GW, Dekker CL, Arvin AM, Greenberg HB.

PLoS One. 2008 Jul 2;3(7):e2574. doi: 10.1371/journal.pone.0002574.

4.

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines.

Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS.

N Engl J Med. 2006 Dec 14;355(24):2513-22.

5.

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, Lewis DB, Dekker CL, Greenberg HB, Arvin AM.

J Virol. 2006 Dec;80(23):11756-66. Epub 2006 Sep 13.

6.

Prospects for universal influenza virus vaccine.

Gerhard W, Mozdzanowska K, Zharikova D.

Emerg Infect Dis. 2006 Apr;12(4):569-74.

7.

Prevention of influenza in the general population.

Langley JM, Faughnan ME.

CMAJ. 2004 Nov 9;171(10):1213-22. Review.

8.

Vaccines for mucosal immunity to combat emerging infectious diseases.

van Ginkel FW, Nguyen HH, McGhee JR.

Emerg Infect Dis. 2000 Mar-Apr;6(2):123-32. Review.

Supplemental Content

Support Center